ALIMA Nurse Activity Manager Jobs in Nigeria
ALIMA has been present in Nigeria since 2016. Its actions are part of a regional response strategy to health and nutrition emergencies, with a focus on pediatric, maternal-infant, and epidemic interventions. ALIMA is present in North-East Nigeria in Borno State (MMC and Jere LGAs) and in Yobe State (Bade and Karasuwa LGAs) where it provides outpatient and inpatient healthcare and nutrition services for IDPs and host communities.
In North-West Nigeria, ALIMA is in Katsina State (Kaita LGA) to respond to increased nutritional needs. ALIMA is present in the South-West, in Ondo State (Owo LGA) where teams are treating patients for Lassa fever and conducting research into improved treatment.
Since the rapid increase in Lassa Fever cases in 2018, ALIMA has been supporting the NCDC and the State Ministry of Health in Owo (Ondo State) with case management, active case detection, patient triage, public awareness campaigns, and reinforcement of the Infection Prevention and Control (IPC) measures among health workers in the different hospital structures of Ondo State.
As of today, ALIMA is intervening in Owo Federal Medical Centre (Owo FMC) to support the response to the outbreak by providing free laboratory and clinical care for suspected and confirmed cases of Lassa fever and also conducting clinical research. In 2019-2020, ALIMA set up a Viral Haemorrhagic Fever laboratory in Owo to improve patients’ care by providing fast and high-quality diagnoses.
In addition to prevention and case management, ALIMA is currently participating in the coordination of several studies to better understand the disease in order to improve case management, including an observational cohort study (LASCOPE) to describe the clinical, biological course, management and outcomes of hospitalized patients with a diagnosis of confirmed Lassa fever.
With more than 1000 inclusions, the LASCOPE study enables researchers and medical experts to better understand the factors that contribute to the death of people infected with the Lassa virus.
It is comprehensively documenting and analyzing the clinical and biological parameters of these patients who were admitted to the Federal Medical Centre in Owo, and more recently to the Alex Ekwueme Teaching Hospital in Abakaliki.
By taking an approach that integrates research, patient care and infection prevention and control, the LASCOPE project provides valuable information for the design of future diagnostic tools, vaccines and therapeutic trials aimed at finding a more specific treatment.
Following the initial results of the LASCOPE study, ALIMA, and its partners are continuing, with the consent of the patients, to collect data on people admitted to the Lassa fever ward in Owo. The study has already produced several publications, including one in The Lancet.
ALIMA is also implementing a phase II clinical trial (SAFARI) at the Federal Medical Center of Owo (FMCO) to evaluate the safety and efficacy of Favipiravir (antiviral drug). The ultimate goal is to improve specific treatment options and continue with an international phase III trial.
All these ongoing and future research activities are in line with ALIMA's strategic priorities to promote research against viral hemorrhagic fevers in Africa.
Mission and Responsibilities
He/she participates in defining, planning, implementing, and monitoring all care and nursing-related activities in accordance with the project plan, ALIMA’s policies, approved guidelines, and procedures.
He/she guarantees the quality of nursing care as well as coordinates human and materials-related resources in collaboration with different health facilities responsible in order
Join in and write your own page! It's easy to do. How? Simply click here to return to Africa Jobs.
Scholarship 2026/27
Current Scholarships 2026/2027 - Fully Funded
Full Undergraduate Scholarships 2026 - 2027
Fully Funded Masters Scholarships 2026 - 27
PhD Scholarships for International Students - Fully Funded!
Funding Opportunities for Journalists 2026/2027
Funding for Entrepreneurs 2026/2027
***